With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...
Q4 2025 Management View CEO Micha Kaufman stated that 2025 was "an execution year, and we delivered," highlighting 10% ...